Latent – Weekly Recap

Latent is a clinical AI company focused on optimizing complex medication access and prior authorization workflows, and this weekly summary highlights several new case studies and partnerships. The company showcased measurable productivity gains at Ochsner Health and emphasized the importance of IT–operations alignment in recent pharmacy collaborations.

At Ochsner Health’s Specialty Pharmacy, Latent-assisted drafting reportedly cut average appeal letter creation time from roughly 30.6 minutes to 7.2 minutes. Benchmarking 91 appeals, the team saw a 75–80% reduction in draft time, reclaiming about 35.4 work hours and enabling pharmacists to process more denials and allocate additional time to direct patient care.

These time savings are operationally significant because prior-authorization denials can slow patient access to critical medications. For healthcare customers and investors, the Ochsner case illustrates how Latent’s tools may protect revenue, increase throughput, and improve payer-response timelines without requiring headcount expansion.

Latent also continued to highlight its earlier deployment at St. Luke’s Health System, where medication access referral backlogs reportedly dropped from about 2,300 items to under 800. St. Luke’s cut prior authorization turnaround times from seven days to three and reduced clinical review time from 18 minutes to five minutes per case, while handling about 1,200 additional prior authorizations per month with existing staff levels.

These results were achieved through a combination of workflow redesign and Latent’s platform, including centralized disease-state pods and redeployment of staff into patient advocate roles. The improvements support Latent’s positioning as an enabler of sustainable capacity expansion and more proactive patient support in high-friction workflows.

In separate updates, Latent emphasized the need for tight alignment between IT and operations when implementing its solutions, citing work with Tower Health and pharmacy leader Ronnie Piszczek. The company stressed that integration with existing systems, security requirements, and daily workflows is central to realizing value and delivering reliable pharmacy operations.

This focus on deeper operational integration suggests a go-to-market strategy centered on complex, high-stakes healthcare environments. If similar outcomes are replicated across more health systems, Latent’s referenceable case studies could support stronger enterprise sales arguments, stickier customer relationships, and recurring revenue opportunities in healthcare automation and documentation AI.

Overall, the week reinforced Latent’s value proposition with concrete metrics from multiple health systems and highlighted its operationally focused approach to deploying clinical AI in pharmacy and prior-authorization workflows.